JST [JINPAN INTERNATIONAL] 6-K: (Original Filing)
[JINPAN INTERNATIONAL LIMITED]
JST [JINPAN INTERNATIONAL] 6-K: JINPAN INTERNATIONAL LIMITED
[JINPAN INTERNATIONAL LIMITED]
CAAS [CHINA AUTOMOTIVE SYSTEMS] 8-K: (Original Filing)
[China Automotive Systems, Inc. to Restate Its Financial Statements Accounting review points to non-cash items related to convertible notes CAAS Company Convertible Notes ASC 815 HUBEI PROVINCE, PRC — March 17, 2011 — China Automotive Systems, Inc. (NASDAQ: CAAS) (“ The Convertible Notes contain an embedded conversion feature that allows for an adjustment to the conversion price in the event] [Form 8-K CURRENT REPORT Date of Report (Date of earliest event reported): March 17, 2011 China Automotive Systems, Inc. Delaware 000-33123 33-0885775 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) No. 1 Henglong Road, Yu Qiao Development Zone Shashi District, Jing Zhou City Hubei Province People’s Republic of China (86) 27-5981 8527 o o o o]
CPHI [CHINA PHARMAS,] 10-K/A: (Original Filing)
[FORM 10-K/A (Amendment No. 1) x For the fiscal year ended December 31, 2010 or For the transition period from _________ to _____________ 001-34471 China Pharmas, Delaware 73-1564807 (State or other jurisdiction oforporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Wensent to theorporation by reference in Registration Statement No. 333-164049 on Form S-3 and Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our reportted March 2, 2011 relating to thensolidated financial statements of China Pharmas, and subsidiaries appearing in this Annual] [CERTIFICATION (Section 302 of therbanes-Oxley Act of 2002) I, Zhilin Li, certify that: 1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION (Section 302 of therbanes-Oxley Act of 2002) I, Frank Waung, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) cphi10kaex312123110.htm 7 EX-31.2] [CERTIFICATION (Section 906 of therbanes-Oxley Act of 2002) (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Zhilin Li cphi10kaex321123110.htm 8 EX-32.1] [CERTIFICATION (Section 906 of therbanes-Oxley Act of 2002) (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) cphi10kaex322123110.htm 9 EX-32.2]
CAAS [CHINA AUTOMOTIVE SYSTEMS] 8-K: China Automotive Systems, Inc. to Restate Its Financial
[China Automotive Systems, Inc. to Restate Its Financial Statements Accounting review points to non-cash items related to convertible notes CAAS Company Convertible Notes ASC 815 HUBEI PROVINCE, PRC — March 17, 2011 — China Automotive Systems, Inc. (NASDAQ: CAAS) (“ The Convertible Notes contain an embedded conversion feature that allows for an adjustment to the conversion price in the event] [Form 8-K CURRENT REPORT Date of Report (Date of earliest event reported): March 17, 2011 China Automotive Systems, Inc. Delaware 000-33123 33-0885775 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) No. 1 Henglong Road, Yu Qiao Development Zone Shashi District, Jing Zhou City Hubei Province People’s Republic of China (86) 27-5981 8527 o o o o]
CPHI [CHINA PHARMAS,] 10-K/A: FORM 10-K/A (Amendment No. 1) x For the
[FORM 10-K/A (Amendment No. 1) x For the fiscal year ended December 31, 2010 or For the transition period from _________ to _____________ 001-34471 China Pharmas, Delaware 73-1564807 (State or other jurisdiction oforporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Wensent to theorporation by reference in Registration Statement No. 333-164049 on Form S-3 and Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our reportted March 2, 2011 relating to thensolidated financial statements of China Pharmas, and subsidiaries appearing in this Annual] [CERTIFICATION (Section 302 of therbanes-Oxley Act of 2002) I, Zhilin Li, certify that: 1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION (Section 302 of therbanes-Oxley Act of 2002) I, Frank Waung, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) cphi10kaex312123110.htm 7 EX-31.2] [CERTIFICATION (Section 906 of therbanes-Oxley Act of 2002) (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Zhilin Li cphi10kaex321123110.htm 8 EX-32.1] [CERTIFICATION (Section 906 of therbanes-Oxley Act of 2002) (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) cphi10kaex322123110.htm 9 EX-32.2]
